New ways to disarm deadly South American hemorrhagic fever viruses

March 09, 2010

New World hemorrhagic fevers are emerging infectious diseases found in South America that can cause terrible, Ebola-like symptoms. Current treatments are expensive and only partially effective.

Now, Howard Hughes Medical Institute (HHMI) researchers have discovered exactly how one type of New World hemorrhagic fever virus latches onto and infects human cells, offering a much-needed lead toward new treatments.

"New World hemorrhagic fevers are nasty, serious, and often fatal diseases," says Stephen C. Harrison, an HHMI investigator at Harvard Medical School and senior author of the report, published March 7, 2010, in Nature Structural & Molecular Biology. "The need for new interventions is high."

Arenaviruses, the infectious agents that cause New World hemorrhagic fevers, circulate naturally in rodents and can infect people who are in close contact with the animals. Symptoms include severe inflammation and bleeding from the mouth, nose, eyes, and other orifices. Most outbreaks occur in rural regions of Bolivia, Venezuela, Argentina, and Brazil. "The outbreaks of New World hemorrhagic fever tend to be brief and brutal, with mortality rates of 20 to 30 percent," says Jonathan Abraham, an M.D./Ph.D. candidate at Harvard University and first author of the paper. "These viruses aren't a huge public health issue yet, but you could say the New World hemorrhagic fevers are an emerging disease threat."

Researchers have known about these viruses since the 1960s, but the molecular basis of the disease has only been tackled recently, says Abraham, whose graduate studies are funded by HHMI through a Gilliam Fellowship for Advanced Study. The Gilliam Fellowships program currently supports the doctoral education of 30 exceptional students from disadvantaged backgrounds.

In 2007, Abraham was working with Boston Children's Hospital virologist Hyeryun Choe when he was co-first author on a report in Nature identifying the human cell surface receptor that the Machupo virus, an arenavirus, grabs to gain access to the human cell it is infecting. The receptor, called transferrin receptor 1, offers a handhold for Machupo virus as it invades cells in the body. Nearly every human cell displays the transferrin receptor, which ferries iron into cells.

Abraham then brought the project to Harrison, who had mentored the young scientist in 2004 as part of HHMI's Exceptional Research Opportunities Program (EXROP), which places undergraduate students from disadvantaged backgrounds in the laboratories of HHMI investigators and HHMI professors. The pairing was fortuitous. In Choe's laboratory, Abraham had developed methods to produce the Machupo virus surface protein, which links to the human transferrin receptor. Meanwhile, Harrison had stocks of purified transferrin receptor because he had previously worked to image the molecule and understood its molecular structure.

Together, the pair made batches of the Machupo surface protein bound to the transferrin receptor and then set about creating an image showing how the two molecules connected. They used x-ray crystallography, a technique in which protein crystals are bombarded with x-ray beams. As the x-rays pass through and bounce off of atoms in the crystal, they produce a diffraction pattern, which can then be analyzed to determine the three-dimensional shape of the protein. After a data collection trip to the powerful x-ray beam at Argonne National Laboratory in Illinois, Abraham and Harrison were able to examine the atomic structure of the Machupo surface protein attached to the transferrin receptor.

The images show that the Machupo surface protein binds to the transferrin receptor in a surprising way-using a loop called the apical domain. The biological function of this loop in humans is unknown, Harrison says. Other segments of the receptor bind iron-bearing transferrin, but the apical domain appears to be uninvolved in that process. "We don't know the normal function of the apical domain. Obviously it didn't evolve just to give Machupo virus a way to infect humans, but that's what the virus has evolved to latch onto," he says.

Because the apical domain is not involved in the critical task of moving iron into cells, Harrison says it presents an attractive target for drugs. In theory, an antibody designed to attach to the apical domain would prevent the Machupo virus from attaching to cells, blocking infection. One possible treatment strategy, then, would be to infuse patients with such an antibody during the early stages of infection, which might slow the infection enough to let patients recover.

Harrison says the finding might also help virologists predict which of the 22 known arenaviruses might be capable of infecting humans. Only five are known to infect humans now-and all of those bind to the human transferrin receptor. Presumably the other 17 viruses produce surface proteins that are unable to bind to the human transferrin receptor, Harrison says.

For Abraham, the idea of finding a treatment for these New World hemorrhagic fevers is close to his heart. His family hails from Haiti, where there is a "huge burden of infectious diseases. I'd like to dedicate my career to studying pathogens in underserved parts of the world," he says.

Howard Hughes Medical Institute

---

---

	Simian Hemorrhagic Fever by Jens Kuhn (Author), Peter B. Jahrling (Editor), Charles H. Calisher (Editor) Simian hemorrhagic fever is an acutely fatal disease of Asian macaques. It is caused by simian hemorrhagic fever virus (SHFV), which is currently classified as an arterivirus in the family Arteriviridae, order Nidovirales. In contrast to its closest relatives, the arterviruses equine arteritis virus, lactate dehydrogenase-elevating virus, and porcine respiratory and reproductive syndrome virus, SHFV is almost completely uncharacterized. Thus far, SHFV has never been isolated from wild animals, and all outbreaks have occurred within primate-holding facilities. Recently, scientific interest in simian hemorrhagic fever has increased in the biodefense community because the disease closely resembles viral hemorrhagic fevers (VHFs) caused by certain arena-, bunya-, flavi-, and filovirids. In...
	Dengue Fever and Other Hemorrhagic Viruses (Deadly Diseases & Epidemics) by Tirtha Chakraborty (Author), Edward I. Alcamo (Editor), David Heymann (Editor)
	Crimean-Congo Hemorrhagic Fever: A Global Perspective by Onder Ergonul (Editor), Chris A. Whitehouse (Editor) This volume covers major aspects of Crimean-Congo hemorrhagic fever (CCHF) and the virus which causes it. Chapters are written by leading experts in their fields and detail historical, public health, epidemiological, and clinical aspects of CCHF and the genetics and molecular biology of the virus. Additional chapters focus on disease control, tick vectors and infection among animals, both natural and experimental.
	The Official Patient's Sourcebook on Marburg Hemorrhagic Fever: A Revised and Updated Directory for the Internet Age by Icon Health Publications (Author) This sourcebook has been created for patients who have decided to make education and Internet-based research an integral part of the treatment process. Although it gives information useful to doctors, caregivers and other health professionals, it also tells patients where and how to look for information covering virtually all topics related to marburg hemorrhagic fever, from the essentials to the most advanced areas of research. The title of this book includes the word official. This reflects the fact that the sourcebook draws from public, academic, government, and peer-reviewed research. Selected readings from various agencies are reproduced to give you some of the latest official information available to date on marburg hemorrhagic fever. Following an introductory chapter, the...
	Omsk hemorrhagic fever: Ecology of the agent and epizootiology by N. N Kharitonova (Author)
	Shipping fever of cattle: Hemorrhagic septicemia (Farmers' bulletin / United States Department of Agriculture) by C. D Stein (Author)
	CRC Handbook of Viral and Rickettsial Hemorrhagic Fever by James H.S. Gear (Author) This standard reference book deals with the diagnosis, treatment, control, and prevention of the hemorrhagic fevers which have at-tracted attention throughout the world because of their severity, high death rate, and their danger to medical and nursing personnel. In Africa they include the recently recognized Lassa fever, Marburg and Ebola virus diseases as well as yellow fever, feared for cen-turies, and Rift Valley fever. In South America where yellow fever still occurs, Junin and Machupo viruses, related to Lassa virus, cause Argentinian and Bolivian hemorrhagic fevers, respectively. Dengue, Korean, Omsk, and Kyasanur hemorrhagic fevers are ex-amples of these conditions occurring in Asia. Crimean-Congo hem-orrhagic fever occurs widely in South Eastern Europe, Asia, and Africa. ...
	Korean hemorrhagic fever and related diseases;: A critical review and a hypothesis by William Livingston Jellison (Author)
	Ebola Virus Haemorrhagic Fever: Colloquium Proceedings by S.R. Pattyn (Editor)
	Pulmonary hemorrhage syndrome associated with an autochthonous case of dengue hemorrhagic fever.(Case Report): An article from: Southern Medical Journal by Robert F. Setlik (Author), Daniel Ouellette (Author), Julia Morgan (Author), Kenneth C. McAllister (Author), David Dorsey (Author), Brian K. Agan (Author), Lynn Horvath (Author), Michelle K. Zimmerman (Author), Bret Purcell (Author) This digital document is an article from Southern Medical Journal, published by Southern Medical Association on July 1, 2004. The length of the article is 2575 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Pulmonary hemorrhage syndrome associated with an autochthonous case of dengue hemorrhagic fever.(Case Report) Author: Robert F. Setlik Publication: Southern Medical Journal (Refereed) Date: July 1, 2004 Publisher: Southern Medical Association Volume: 97 Issue: 7 Page: 688(4) Distributed by Thomson...